Workflow
和邦生物(603077) - 2018 Q1 - 季度财报
HBCHBC(SH:603077)2018-04-27 16:00

Financial Performance - Total revenue for Q1 2018 reached RMB 1,151,399,395.25, representing a 24.05% increase compared to RMB 928,147,041.22 in the same period last year[6] - Net profit attributable to shareholders was RMB 49,809,631.43, a decrease of 71.03% from RMB 171,959,328.29 year-on-year[6] - Basic earnings per share fell to RMB 0.01, a 50% decrease from RMB 0.02 in the same period last year[6] - The total profit for the period was CNY 56,838,825.81, down from CNY 204,182,417.60, indicating a decline of 72.1% year-over-year[24] - The operating profit for Q1 2018 was CNY 56,110,216.50, a significant decrease from CNY 203,608,851.85 in the same quarter last year[24] - The company's total comprehensive income for the period was CNY -14,738,408.09, compared to CNY 166,252,338.05 in the previous year[24] Cash Flow - The net cash flow from operating activities improved to RMB 9,922,141.14, compared to a negative RMB 191,009,398.37 in the previous year[6] - Cash inflow from operating activities amounted to ¥508,476,662.00, a substantial increase from ¥243,462,692.86 year-over-year[29] - The net cash flow from operating activities for Q1 2018 was ¥34,405,158.09, compared to a negative cash flow of ¥59,590,434.73 in the same period last year, indicating a significant improvement[29] - Cash inflow from financing activities totaled ¥60,000,000.00, up from ¥30,000,000.00 in the previous year, indicating increased borrowing[30] - The net cash flow from financing activities was ¥55,371,591.69, a significant recovery from a negative cash flow of -¥125,248,991.30 in the same period last year[30] Assets and Liabilities - Total assets at the end of the reporting period were RMB 13,058,110,561.52, a slight decrease of 0.39% from RMB 13,108,789,692.28 at the end of the previous year[6] - Total liabilities decreased slightly to CNY 1,794,906,772.18 from CNY 1,833,864,544.58, indicating a reduction in financial obligations[19] - Non-current liabilities increased to CNY 575,648,472.45 from CNY 515,725,685.29, reflecting potential long-term financing activities[19] - The company reported a total asset value of CNY 11,123,685,377.29, up from CNY 11,073,822,710.24, indicating overall growth in asset base[21] Shareholder Information - The total number of shareholders reached 171,687, with the largest shareholder holding 33.25% of the shares[10] - Net assets attributable to shareholders increased marginally by 0.07% to RMB 10,994,821,944.93 from RMB 10,987,635,300.57[6] Operational Costs and Expenses - Operating costs increased by 51.03% to ¥947,500,827.87 due to routine maintenance and supply chain issues affecting production capacity[13] - Financial expenses surged by 1291.15% to ¥15,312,744.88 due to increased borrowings[13] - The company incurred a financial expense of CNY 12,853,294.47, which increased from CNY 4,546,159.04 in the previous year[25] Inventory and Receivables - Accounts receivable decreased by 30.08% to ¥619,443,630.14 due to the collection of matured acceptance bills[12] - Inventory increased to ¥1,158,376,826.79 from ¥1,063,768,203.76, indicating a buildup of stock[17] - Other receivables increased by 43.84% to ¥1,955,079.75 mainly due to an increase in employee advances[12]